![](https://www.israelandstuff.com/wp-content/uploads/2020/04/Schematic-diagram-of-the-Coronavirus-particle.-Illustration-Wikimedia-MS-Binte-altaf--150x150.png)
With the U.S. Food and Drug Administration’s approval for phase two trials, researchers are hoping that the Israeli drug Aviptadil, will be able to eliminate the so-called Acute Respiratory Distress Syndrome (ARDS), the condition responsible for the deaths of about 50% of all COVID-19 patients.
By i24NEWS
The U.S. Food and Drug Administration on Sunday has cleared NeuroRx, a US-Israeli pharmaceutical company, and Relief Therapeutics, a Swiss drug development company, for phase two trials for a drug that could take on a deadly condition associated with COVID-19.
The two companies announced that the FDA issued a “study may proceed” letter — which does not amount to a full-fledged drug approval — for the substance to be tried on COVID-19 patients. Continue Reading »